Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | STAT1 | P42224 | 1/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 4/20 | 0.46 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24155750 | 0.94 | NPC1 (0.49) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL24586957 | 0.93 | NPC1 (0.48) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL24155541 | 0.91 | NPC1 (0.46) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL26098802 | 0.89 | NPC1 (0.47) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL24156146 | 0.87 | NPC1 (0.43) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL8964867 | 0.86 | ALDH1A1 (0.61) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL24156198 | 0.86 | PTPN5 (0.43) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL24156176 | 0.85 | BCHE (0.44) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL23384463 | 0.85 | NPC1 (0.54) | NPC1RAB9AMAPTHPGDKDM4E | |
| SCHEMBL24155424 | 0.84 | NPC1 (0.45) | NPC1RAB9AMAPTHPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812657-B2 | Organic electric element | DUK SAN NEOLUX CO., LTD. | 2023-11-07 | — | — | US | disclosed |
| US-11812657-B2 | Organic electric element | DUK SAN NEOLUX CO., LTD. | 2023-11-07 | — | — | US | disclosed |
| US-20230276699-A1 | Organic Electric Element | DUK SAN NEOLUX CO LTD (KR) | 2023-08-31 | — | — | US | disclosed |
| US-20230276699-A1 | Organic Electric Element | DUK SAN NEOLUX CO LTD (KR) | 2023-08-31 | — | — | US | disclosed |
| US-20220209127-A1 | ORGANIC ELECTRIC ELEMENT | DUK SAN NEOLUX CO., LTD (KR) | 2022-06-30 | — | — | US | disclosed |
| WO-2021261851-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT | 덕산네오룩스 주식회사 | 2021-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230276699-A1 | Organic Electric Element | EPCAM, ESR1, SOD1 | NPC1 3567/4885RAB9A 2856/4885MAPT 1628/4885 |
| US-20220209127-A1 | ORGANIC ELECTRIC ELEMENT | EPCAM, ESR1, SOD1 | NPC1 3567/4885RAB9A 2856/4885MAPT 1628/4885 |
| US-11812657-B2 | Organic electric element | EPCAM, ESR1, SOD1 | NPC1 3567/4885RAB9A 2856/4885MAPT 1628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.